Breast Cancer News
67.5K views | +4 today
 
Scooped by Susan Zager
onto Breast Cancer News
Scoop.it!

Clinical Oncology News - By the Numbers

Clinical Oncology News - By the Numbers | Breast Cancer News | Scoop.it

"Noncompliance with aromatase inhibitor (AI) therapy within the first year is associated with patient-reported symptoms before initiation of AI therapy, particularly poor sleep quality. This finding comes from a study of 503 patients being treated with AIs, presented at the recent San Antonio Breast Cancer Symposium (S3-02). According to the researchers, up-front management of these symptoms and treating the constellation of symptoms, rather than focusing on individual symptoms, may improve compliance with AI therapy."

more...
No comment yet.
Breast Cancer News
Latest News, Research,  Articles of Interest, and Blog Posts
Curated by Susan Zager
Your new post is loading...
Scooped by Susan Zager
Scoop.it!

Androgen Receptor Antagonists Approach Primetime for Breast Cancer

Androgen Receptor Antagonists Approach Primetime for Breast Cancer | Breast Cancer News | Scoop.it
Existing data for androgen receptor (AR) antagonists are encouraging and anticipated future results could soon show a benefit for these agents in large populations of patients with breast cancer.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

The invisible cure. Should we be talking more about cancer surgery? – Cancerworld

The invisible cure. Should we be talking more about cancer surgery? – Cancerworld | Breast Cancer News | Scoop.it
Susan Zager's insight:

Great article! 

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

UCF Technology for Killing Metastatic Breast Cancer Cells Discovered, Licensed

UCF Technology for Killing Metastatic Breast Cancer Cells Discovered, Licensed | Breast Cancer News | Scoop.it
UCF Technology for Killing Metastatic Breast Cancer Cells Discovered, Licensed - Read more about UCF Colleges & Campus News, Community, Health & Medicine, Student Life, Orlando and Central Florida news.
Susan Zager's insight:

While in early stages for clinical trials, this aspect of MBC research is another chance to really find away to stop mets from progressing and killing. 

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Fairfield Doctor Says Metastatic Breast Cancer Sufferers Need More Support

Fairfield Doctor Says Metastatic Breast Cancer Sufferers Need More Support | Breast Cancer News | Scoop.it
Dr. Rebecca Timlin-Scalera, a neuropsychologist, experienced a "reversal of fortune" that changed everything.
Susan Zager's insight:
Fascinating story about
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

California senator withdraws drug price transparency bill

California senator withdraws drug price transparency bill | Breast Cancer News | Scoop.it
The decision came after amendments were made during an assembly committee hearing that sources said “effectively gutted” the legislation.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

‘My dog has found 550 cancers.. and he saved my life’: Meet the amazing pooch that sniffs out killer disease

‘My dog has found 550 cancers.. and he saved my life’: Meet the amazing pooch that sniffs out killer disease | Breast Cancer News | Scoop.it
THIS is the dog that can sniff out cancer in seconds – and is revolutionising the way we diagnose the disease
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

The sobering thing doctors do when they die

The sobering thing doctors do when they die | Breast Cancer News | Scoop.it
Doctors do the opposite of what they say want to do when they die
Susan Zager's insight:
Fascinating look at doctors and patients choices when dying. It's interesting that the article notes that Doctors usually choose less treatment and longer time in hospice. There is so much pressure to keep doing aggressive drugs that sometimes cause more progression and other side effects that end up being more harmful. Very thought provoking.
To see the original study go to: http://onlinelibrary.wiley.com/doi/10.1111/jgs.14112/abstract
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

New technology helps ID aggressive early breast cancer

New technology helps ID aggressive early breast cancer | Breast Cancer News | Scoop.it
Researchers at the University of Michigan developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties.
Susan Zager's insight:

This technology will take time but it's the most no-aggressive way to go.

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Cancer, bankruptcy and death: study finds a link

Cancer, bankruptcy and death: study finds a link | Breast Cancer News | Scoop.it
A new study conducted by Fred Hutch's HICOR group has found that the 3 percent of cancer patients who go bankrupt are more likely to die. We talk to study author Dr. Scott Ramsey.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

We’re spending $107 billion on cancer drugs, but is it worth it?

We’re spending $107 billion on cancer drugs, but is it worth it? | Breast Cancer News | Scoop.it
The wave of new cancer treatments may not lengthen patients' lives much.
Susan Zager's insight:

The cost of cancer drugs is growing and expensive. Carolyn Johnson takes an important look on where money is spent and what is getting results as well as where the problems are.

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

What You Need to Know About the World's Biggest Cancer Conference

What You Need to Know About the World's Biggest Cancer Conference | Breast Cancer News | Scoop.it
Doctors and biopharma giants will congregate in Chicago on Friday for ASCO's annual meeting, the biggest cancer conference in the business.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Fighting to tame metastatic breast cancer

Fighting to tame metastatic breast cancer | Breast Cancer News | Scoop.it
As sleety rain kept falling, the activists anguished about whether to go ahead with plans to lie on the ground on a recent Saturday evening. Their "die-in" was intended to symbolize the fact that,
Susan Zager's insight:
Proud to be a part of this DieIn. Great article about many people working to get funding for so many #dyingforacure
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Pictilisib for Estrogen Receptor–Positive, Aromatase Inhibitor–Resistant, Advanced or Metastatic Breast Cancer

Pictilisib for Estrogen Receptor–Positive, Aromatase Inhibitor–Resistant, Advanced or Metastatic Breast Cancer | Breast Cancer News | Scoop.it
Pictilisib for Estrogen Receptor–Positive, Aromatase Inhibitor–Resistant, Advanced or Metastatic Breast Cancer
Susan Zager's insight:

You made need to sign in for the article, but it's worth it. To see the original study go to: http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)00106-6/abstract?cc=y=

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Financial Toxicity and Cancer Treatment

Financial Toxicity and Cancer Treatment | Breast Cancer News | Scoop.it
Expert-reviewed information summary about the risk of experiencing financial difficulty during cancer treatment.
Susan Zager's insight:

The difficulties of finances on top of side effects from treatments all causes issues for cancer patients. 

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

How to Read Beyond the Headline: 9 Essential Questions to Evaluate Medical News

How to Read Beyond the Headline: 9 Essential Questions to Evaluate Medical News | Breast Cancer News | Scoop.it
How to Read Beyond the Headline: 9 Essential Questions to Evaluate Medical News Ben Goldacre writing in Bad Science classified science reporting as falling into
Susan Zager's insight:
Marie does an awesome break down explaining the important questions one should ask when reading any scientific article.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Study Of Breast Cancer Treatment Reveals Paradox Of Precision Medicine

Study Of Breast Cancer Treatment Reveals Paradox Of Precision Medicine | Breast Cancer News | Scoop.it
A genetic test of breast cancer tumors helped identify women whose survival odds would not be greatly improved by chemotherapy. But that test isn't as precise as women and doctors might like.
Susan Zager's insight:

This article does a great job explaining the significance without hyping misleading headlines and value to the article. 

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Research on Vaccines for Breast Cancer Proceeding

None FDA approved to date, but interesting research is ongoing.
Susan Zager's insight:
Lots of #research but no FDA approved to date,. The research is ongoing.as we hope for combination vaccines and medications that reverse terminal progression (MBC)
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

On the hunt for genetic clues to breast cancers that spread to the brain — UNC Lineberger Comprehensive Cancer Center

On the hunt for genetic clues to breast cancers that spread to the brain — UNC Lineberger Comprehensive Cancer Center | Breast Cancer News | Scoop.it
UNC Lineberger researcher Carey Anders, MD, wants to understand why some breast cancers metastasize to the brain, and what drives them.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Why Democratic convention viewers saw so many drug ads

Why Democratic convention viewers saw so many drug ads | Breast Cancer News | Scoop.it
Drug makers advertised heavily at the Democratic National Convention to promote their products — and their industry.
Susan Zager's insight:
Drug ads have been a major frustration. It wastes huge amounts of money and we pay the price. It's a tough dance when you need drugs to save your life and have to be subjected to their wasting money that could be spent on metastatic research.
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

A Modern, Adaptive FDA Should Support Patients' Right To Try New Medications

A Modern, Adaptive FDA Should Support Patients' Right To Try New Medications | Breast Cancer News | Scoop.it
The agency’s leadership might accomplish what medicine does best: applying science humanely, so that people can get well if it’s possible, and not wait.
Susan Zager's insight:
This article by Elaine Schattner looks at the issues with medications and the FDA approvals when patients need certain meds to stay alive.
Here's some great quotes, while we recommend reading the full article.

Elaine writes:
"A little-cited fact is that many of the 97% cancer patients who aren’t on clinical trials aren’t on study because they don’t qualify for a trial. It’s not that they or their doctors don’t want to participate.
Access to life-saving drugs, within the FDA evaluation system, shouldn’t be based on a patient’s wealth or connections. I’m excited about the FDA’s news, establishing an oncology center related to the Cancer Moonshot. This should expedite the careful and informed evaluation and approval of new drugs, diagnostic tools and medical devices. Ihope the efforother diseases".
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Biden holding cancer summit to pump up support for ‘moonshot’ effort

Biden holding cancer summit to pump up support for ‘moonshot’ effort | Breast Cancer News | Scoop.it
Meetings in Washington and around the country Wednesday will focus on research needs.
Susan Zager's insight:
Check out your local areas and also links to live satellite if you can't travel. From USC go to: http://keckmedia.usc.edu/Mediasite/Catalog/catalogs/Cancer-Moonshot-Summit
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

21st Century Cures Act nears passage with little news media scrutiny

21st Century Cures Act nears passage with little news media scrutiny | Breast Cancer News | Scoop.it
Veteran health care reporter and regular HealthNewsReview.org blogger Trudy Lieberman has been following the 21st Century Cures Act’s journey through Congr
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Despite ASCO Mishap, Data Still Intriguing for Sacituzumab Govitecan in TNBC | Onclive

Despite ASCO Mishap, Data Still Intriguing for Sacituzumab Govitecan in TNBC | Onclive | Breast Cancer News | Scoop.it
Sacituzumab govitecan (IMMU-132) had an objective response rate of 33% in pretreated patients with triple-negative breast cancer, according to updated findings from a phase II study reported by Immunomedics, the manufacturer of the antibody-drug conjugate.
Susan Zager's insight:

This study was excluded from the conference when ASCO became aware that its meeting embargo had been violated when the chairman of Immunomedics reported the results at a conference in April. Meanwhile the author of this article, Jason Broderick, looks at the important findings. 

more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

June 4, 2016: Chicago

June 4, 2016: Chicago | Breast Cancer News | Scoop.it
Right Patient, Right Treatment, Right Now Doctors, Patients, Experts and Advocates Help You Survive the Attacks on YOUR Treatments Join us for our CALL TO ACTION: Right Patient, Right Treatment, Right Now FACTS: The Obstacles to Access CLARITY:...
Susan Zager's insight:
Looks interesting!
more...
No comment yet.
Scooped by Susan Zager
Scoop.it!

Compassion & Choices | Medical Aid in Dying Act Wins Swift Assembly Committee Vote

Compassion & Choices | Medical Aid in Dying Act Wins Swift Assembly Committee Vote | Breast Cancer News | Scoop.it
Susan Zager's insight:
Hopefully many more states will follow along.
more...
No comment yet.